PATIENT DECISIONAL NEEDS REGARDING SCREENING AND PROPHYLACTIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

Patients often learn of arrhythmogenic right ventricular cardiomyopathy (ARVC) risk after experiencing an arrhythmic episode. A definitive diagnosis of ARVC is multifaceted and includes genetic testing (screening). Some patients are offered an implantable cardioverter defibrillator (ICD) as prophylaxis for sudden cardiac death. This study sought to understand patient decisional needs and preferences about ARVC. We recruited a small cohort of...